JNJ : Analysis & Opinions

  • Showing 1-100 of 196 items
  • 1
  • 2
  • >>
  1. Failed Mergers Cast Shadow on Sanofi's Future

    January 23, 2017
    Two failed acquisitions have cast a long shadow on Sanofi's prospects.
  2. Canada Wants Painkiller Warnings as Deaths Soar

    January 23, 2017
    Amid rising painkiller-related deaths, Canada wants to use cigarette-style warning stickers.
  3. Johnson & Johnson Earnings Out Tuesday, What to Expect?

    January 23, 2017
    Having beaten Wall Street's earnings estimates in twelve straight quarters, JNJ has maintained its growth momentum in the ...
  4. What To Focus On When JNJ Reports Q4 Results

    January 22, 2017
    JNJ reports Q4 and Full Year 2016 results the morning of Tuesday January, 24th. What will the dollar's value do to results?
  5. Even a 15% Tax Rate May Not Help Pharmaceuticals

    January 19, 2017
    Will a lower corporate tax rate help bring more profit to the industry? They may already be doing it on their own.
  6. In This Case Silence Could be Golden

    January 17, 2017
    Healthcare stocks are falling again ahead of Friday's transition of power.
  7. Top Stocks to Watch in 2017

    January 10, 2017
    Part of your new year's resolution might include keeping an eye on these stocks.
  8. Piper Bullish On Pfizer and Eli Lilly

    January 9, 2017
    Today, Piper mentioned that it likes Pfizer and Eli Lilly and is less a favorable on Merck and Johnson & Johnson.
  9. Biosimilar Drugs To Take On Top Brand Names

    January 4, 2017
    Makers of biosimilar drugs may erode the market share of top brand names as competition heats up.
  10. Johnson & Johnson Set for Strong Recovery (JNJ)

    January 3, 2017
    Johnson & Johnson may have ended its intermediate correction in December, with highs odds for new bull market and all-time ...
  11. Healthcare Stocks Struggled in 2016

    December 30, 2016
    Healthcare stocks struggled all year. Things may be looking up in the new year.
  12. J&J and Actelion Could Be Close To A Deal

    December 29, 2016
    According to a Reuters report, Johnson & Johnson, and Actelion could be close to an agreement.
  13. Johnson & Johnson is Talking to Actelion, Again

    December 21, 2016
    J&J's on again, off again, romance with Actelion appears to be heating up again.
  14. Did Actelion Get A Deal It Couldn't Refuse? (JNJ)

    December 13, 2016
    J&J and Actelion have ended deal talks, new offer has yet to appear.
  15. Report on PFE and JNJ Are Moving the Stocks Higher

    December 12, 2016
    A positive article on Johnson & Johnson and a Pfizer dividend increase are boosting their shares, and the group higher.
  16. Will Johnson & Johnson Take Over Actelion?

    December 7, 2016
    Silence from Actelion has some hedge fund managers wondering if Johnson & Johnson will purchase the smaller Swiss biotech ...
  17. Amazon Set To Wage War On Counterfeits

    November 29, 2016
    The e-commerce behemoth has plans to set up a brand registry for merchants wishing to sell on its site.
  18. Is the Johnson & Johnson Bid for Actelion a Growth Play? (JNJ)

    November 28, 2016
    Both Johnson & Johnson and Actelion have recently confirmed they are both in preliminary acquisition talks.
  19. JNJ May Acquire Swiss Drug Maker Actelion (JNJ)

    November 28, 2016
    Johnson & Johnson is in preliminary talks to acquire Europe's largest biotech firm, Actelion.
  20. JNJ’s High-Cost Leukemia Drug Cleared in UK (JNJ)

    November 25, 2016
    Johnson and Johnson's costly Imbruvica pill for lymphocytic leukemia will be made available in Britain after JNJ agreed to ...
  21. JNJ’s Darzalex Myeloma Drug Wins FDA Nod (JNJ)

    November 23, 2016
    The combination therapy, approved last year for use after three earlier treatments failed, has now won FDA approval after ...
  22. Billionaire John Paulson Trims JNJ, Teva, Adds CVS: 13F Filing

    November 15, 2016
    It's not hard to see why Paulson was bearish health care, given the public stance Hilary Clinton had taken amid the price ...
  23. J&J’s Humira Rival Needs More Work (JNJ, ABBV)

    November 15, 2016
    J&J’s rheumatoid arthritis drug sirukumab produced mixed results in a recent study.
  24. Amgen, Janssen to Begin Myeloma Trial (AMGN, JNJ)

    November 11, 2016
    The companies will launch combination drug studies to treat multiple myeloma, or cancer of the plasma cells.
  25. Opioid Makers Targeted in Lawsuits (JNJ, AGN)

    October 28, 2016
    Several states are suing opioid makers like Allergan and Johnson & Johnson, citing the alarming increase in painkiller addiction.
  26. No Quick Remedy for Johnson & Johnson Downside

    October 17, 2016
    Johnson& Johnson has lost ground since hitting an all-time high in July while shareholders have abandoned ship, for growth ...
  27. Xarelto Blood Thinner Gets FDA Clearance (JNJ)

    October 13, 2016
    The FDA cleared Xarelto blood thinner as safe for atrial fibrillation, paving the way for increased sales by drug makers ...
  28. Global Licensing Deal Spikes Geron Stock (GERN, JNJ)

    September 23, 2016
    Building upon an existing 2014 agreement, Geron and Jenssen have struck a renewed global partnership on multiple products.
  29. Procter & Gamble Is Losing Shelf Space Clout

    September 23, 2016
    The battle for the bathroom rages on, and Procter & Gamble (NYSE: PG) is getting washed out. A report by Bloomberg Intelligence ...
  30. Three Mega-Cap Stocks Crushing the S&P 500 (MSFT, XOM)

    September 19, 2016
    You don't need volatile small-cap stocks to beat the market
  31. J&J Buys Abbott's Eye Health Unit for $4.3 Billion

    September 19, 2016
    Johnson & Johnson (NYSE: JNJ) has obviously been keeping its eyes peeled for  big-time acquisitions: The company just ...
  32. 4 Books Teresa Clarke Is Reading

    September 16, 2016
    Teresa Clarke, former Goldman Sachs investment banking director and current head of Africa.com, has put together an interesting ...
  33. Most Profitable Health Care Companies of 2016 (GILD, JNJ)

    September 15, 2016
    All four of the most profitable health care companies listed on U.S. exchanges reported net income exceeding $2 billion during ...
  34. Top 6 Pharmaceutical Companies Globally

    August 23, 2016
    Johnson & Johnson leads the pack in both market cap and revenue.
  35. Top 5 Drug Stocks of 2016 (ABBV, JNJ)

    August 19, 2016
    Discover analyses of the top five drug stocks, and learn why investors should consider these stocks due to the stocks' attractive ...
  36. Top 5 Pharmaceutical Stocks of 2016 (ABBV, JNJ)

    August 9, 2016
    These 5 top-performing pharmaceutical stocks have 2016 product offerings and pipeline prospects that make them a solid bet ...
  37. Eli Lilly President/CEO to Retire at Year's End

    July 28, 2016
    This will be the final year of Eli Lilly (NYSE: LLY) President and CEO John Lechleiter's tenure. The company has announced ...
  38. Johnson & Johnson Q2 Earnings, Guidance Beat (JNJ)

    July 19, 2016
    Combined with its upbeat outlook, the company's confidence affirms that its 20% year-to-date stock gains have been no fluke.
  39. What to Expect in Johnson & Johnson Earnings (JNJ)

    July 18, 2016
    JNJ has beaten Wall Street's earnings estimates in 10 straight quarters, maintaining its growth momentum in the face of competitive ...
  40. Dow Jones Industrials Reach All-Time High (JNJ, GE)

    July 13, 2016
    The Dow followed the S&P 500 into record territory yesterday. Here are some stocks that benefited from the upside.
  41. Behind Johnson & Johnson's 91.5% Rise in 10 years (JNJ)

    July 10, 2016
    Analyze Johnson & Johnson's historical stock price performance. Learn how equity valuations, operating fundamentals and health ...
  42. A Look Inside the Vanguard Dividend Appreciation ETF

    July 7, 2016
    The VIG, which has $25.4 billion in net assets, is designed to track the performance of the NASDAQ US Dividend Achievers ...
  43. A Look at the iShares Enhanced U.S. Large-Cap ETF (IELG, JNJ)

    July 6, 2016
    As of July 1, the IELG consisted of 109 individual stocks, with the information technology sector accounting for about 3 ...
  44. A Look at the Health Care Select Sector SPDR Fund (XLV, JNJ)

    July 5, 2016
    Components of the XLV are projected to yield an average earnings growth rate of 10.46% in the next three to five years.
  45. Lower for Longer: Negative Yield in Corporate Bonds (BAC, JNJ)

    June 25, 2016
    Discover why for the first time in history, corporate bonds will drop into negative yield territory, joining sovereign bonds ...
  46. Top 2 Holdings of Columbia Threadneedle's Mutual Fund (MSFT, ...

    June 18, 2016
    Discover the two AAA-rated by S&P top holdings of the Columbia Dividend Income fund: Microsoft Corp. and Johnson & Johnson.
  47. J&J's Vogue Purchase Complements its Beauty Business (JNJ)

    June 9, 2016
    Johnson & Johnson has purchased hair care product maker Vogue. Here's a look at the deal.
  48. Samsung Moves to List Bioepis for $2.5B

    June 9, 2016
    With European approval for Flixabi, Samsung Bioepis appears all set for its awaited IPO.
  49. The Top 4 UPS Shareholders (UPS)

    June 7, 2016
    Learn about the history of United Parcel Service Inc., and the shipping company's top four largest individual shareholders, ...
  50. Which 2 U.S. Companies Are Still Rated AAA? (JNJ)

    June 7, 2016
    If there are only two U.S. companies with a AAA rating, then they should definitely be on your watch list.
  51. The Share Buyback Report: Health Care Sector (PFE, JNJ)

    June 3, 2016
    Analyze health care sector share repurchase data to identify trends. Determine which factors influence volume and which companies ...
  52. Why Johnson & Johnson Paid $3 Billion for Shampoo

    June 2, 2016
    That's one expensive bottle: Johnson & Johnson (NYSE: JNJ) just bulked up its consumer products division with an agreement ...
  53. Johnson & Johnson Initiated With Sell Rating (JNJ)

    May 30, 2016
    JNJ stock has a consensus hold rating and an average analyst 12-month price target of $117, implying an 3.48% rise from current ...
  54. Stay Defensive with Your Summer Portfolio

    May 28, 2016
    With odds of a rate hike increasing, and an election in November, investors should look to rotate towards the defensive sectors ...
  55. VHT: Vanguard Health Care ETF Performance Analysis

    May 26, 2016
    Discover how the Vanguard Health Care ETF performed through bear and bull markets, and learn which holding is trouncing the ...
  56. BMO's Top 3 U.S. Dollar Mutual Funds (BMO, AAPL)

    May 23, 2016
    Take a look at three U.S. dollar-denominated mutual funds from BMO Financial Group targeted at Canadian investors interested ...
  57. The Top 5 Johnson & Johnson Shareholders (JNJ)

    May 23, 2016
    Learn about the origins of Johnson & Johnson as the company turns 130 and the health care conglomerate's five largest shareholders.
  58. Johnson & Johnson Stock Trades Ex-Dividend Friday (JNJ)

    May 20, 2016
    Johnson & Johnson will send its dividend payment on June 7 to shareholders of record as of May 24.
  59. 5 Stocks to Hold Forever

    May 18, 2016
    Based on market share and fundamentals, it would be difficult to lose if you held these five stocks long term.
  60. (ADHD) Who are Alcobra's Main Competitors?

    May 8, 2016
    Learn about Alcobra, a young player in treating attention deficit hyperactiviy disorder (ADHD) that may give its competitors ...
  61. Legal Risk Study: XLV, How Much Fines Have Component Companies ...

    May 8, 2016
    Learn the reasons behind the fines paid by the top three pharmaceutical companies held by XLV, and why they might not prevent ...
  62. J&J Loses Second Talcum Powder Cancer Case

    May 4, 2016
    A jury recently ordered Johnson & Johnson to pay $55 million in damages to a woman who claimed that its talcum powder ...
  63. JNJ to Pay $55 Million in Ovarian Cancer Suit (JNJ)

    May 3, 2016
    Health care giant Johnson & Johnson was ordered to pay $55 million in damages to a woman who claimed that the company's talcum ...
  64. XLG vs. MGC: Comparing Mega-Cap ETFs

    May 2, 2016
    Discover how mega-cap stocks have fared in 2016 and read a comparative analysis of the Guggenheim S&P 500 Top 50 ETF and ...
  65. Johnson & Johnson Stock Boosted By Dividend Hike (JNJ)

    May 2, 2016
    Shares of Johnson & Johnson may trade at near 52-week highs, but don't hold your breath waiting for its stock price to get ...
  66. SSO vs. UPRO: Comparing Leveraged U.S. Equity ETFs

    May 2, 2016
    Discover how the leveraged exchange-traded-fund SSO compares to UPRO, and determine which one is the right fit for your portfolio ...
  67. GSLC: Goldman's Large Cap ActiveBeta ETF

    May 1, 2016
    Learn about Goldman Sachs' new ActiveBeta exchange-traded funds, and discover an analysis and the characteristics of the ...
  68. QQQ vs. OEF: Comparing Large Cap ETFs

    April 27, 2016
    Discover and compare two large-cap exchange-traded funds (ETFs). Learn about their purposes, strategies, characteristics ...
  69. Global Health Care Technology: 5 Key Industry Players (JNJ, GSK)

    April 27, 2016
    Discover how to analyze which of these top five key global health care technology industry players best suit your portfolio ...
  70. The Top 5 Companies Paying Dividends (JNJ, XOM)

    April 25, 2016
    Explore analyses of the top five dividend-paying companies, and learn about their trailing 12-month dividend payouts and ...
  71. The 3 Largest Health Care ETFs (XLV, IBB)

    April 25, 2016
    Find out which exchange-traded funds (ETFs) are the largest in terms of total assets under management (AUM) in the health ...
  72. 5 Reliable Dividend Stocks

    April 22, 2016
    We quickly analyze five stocks that have rewarded investors over the long haul. Here's why they may make some sense for your ...
  73. Are Johnson & Johnson's Earnings Estimates Too Healthy? (JNJ)

    April 19, 2016
    Have analysts' upward revision earnings estimates for Johnson & Johnson gotten ahead of themselves?
  74. Top 3 Stocks to Invest in If You Can't Stand Risk

    April 18, 2016
    Don't have the appetite for risk? Consider these 3 stocks.
  75. DIA vs. IWL: Comparing ETFs with the Largest U.S. Companies

    April 15, 2016
    Find out how the SPDR Dow Jones Industrial Average ETF compares with the iShares Russell Top 200 as mega-cap exchange-traded ...
  76. St. Jude Medical is Turning the Corner (STJ)

    April 14, 2016
    A review of St. Jude Medical's business operations, financials, valuation and growth drivers.
  77. VTI vs. IWV: Comparing Total Market ETFs

    April 9, 2016
    Find out how the Vanguard Total Stock Market Index ETF compares with the iShares Russell 3000 ETF in terms of portfolio composition, ...
  78. AI: These Companies Are Leading the Way

    April 6, 2016
    AI is about to show its mainstream worth. Here are the companies leading the way.
  79. IELG vs. IESM: Reviewing iShares U.S. Enhanced ETFs

    March 31, 2016
    Examine two actively managed equity ETF offerings from iShares, one focused on large-cap stocks and the other focused on ...
  80. Johnson & Johnson Makes New 52-Week High (JNJ)

    March 29, 2016
    You would be hard pressed to find a large-cap healthcare stock with a combination of growth potential and value.
  81. Exploring Schwab's Suite of Inexpensive U.S. Equity ETFs (SCHX, ...

    March 25, 2016
    Discover Schwab's most popular low-cost exchange-traded funds (ETFs) for equities, which are also highly ranked by Morningstar.
  82. 4 Best Dividend-Paying U.S. Equity ETFs (HDV)

    March 24, 2016
    Find out which U.S. equity dividend-paying exchange-traded funds are the best for dividend yield, total return performance ...
  83. VWINX: Overview of Vanguard Wellesley Income Fund

    March 19, 2016
    Learn the highlights of the Vanguard Wellesley Income Fund in this overview, including its investment objective, management ...
  84. (VT) Vanguard Total World Stock Index ETF: Top 5 Holdings

    March 19, 2016
    Find out which of the world's most valuable companies hold the top five positions in the Vanguard Total World Stock Index ...
  85. (VHT) Vanguard Healthcare ETF: Top 5 Holdings

    March 19, 2016
    Identify the top five holdings in the Vanguard Health Care exchange-traded fund (ETF), and evaluate each holding's business ...
  86. Overview of Vanguard Balanced Index Fund (VBINX)

    March 19, 2016
    Find out about the Vanguard Balanced Index Inv in this fund overview, which includes highlights of its management, portfolio ...
  87. 4 Defensive ETFs Worth Your While (VHT, PGX)

    March 19, 2016
    Find out which top exchange-traded funds (ETFs) would be well worth your consideration when deploying a defensive investment ...
  88. (XLV) Healthcare SPDR ETF: Top 5 Holdings

    March 18, 2016
    Discover the top five stocks in the Health Care Select Sector SPDR Fund, and learn if they can help power your portfolio ...
  89. The 5 Highest Paid Executives in the Healthcare Sector (AGN, ...

    March 18, 2016
    Discover who the highest paid executives in the health care sector are and how much they make, while the cost of health care ...
  90. Johnson & Johnson To Pay $502M Over Hip Implants (JNJ)

    March 18, 2016
    The jury's decision is the result of a two-month trial and is one of several (around 8,000 other cases) that are pending ...
  91. The 3 Biggest Healthcare Stocks in the S&P 500 ETF (SPY, JNJ)

    March 17, 2016
    Discover the three biggest health care companies in the SPY ETF, and learn how they could power your portfolio performance ...
  92. SPY S&P 500 SPDR ETF: Top 5 Holdings (AAPL, MSFT)

    March 16, 2016
    Learn about how the history of the SPDR S&P 500 ETF and how it is managed. Discover the top five stock positions held within ...
  93. 5 Mutual Funds for Dividend Investors from Morningstar (VDIGX, ...

    March 16, 2016
    Find out which five highly rated dividend funds are Morningstar favorites for their strong yields and overall performance ...
  94. Healthcare Sector: Industries Snapshot (XLV, JNJ)

    March 15, 2016
    Discover the six industries that make up the health care sector in the Standard and Poor's 500, and learn which companies ...
  95. J&J's Partnership with IBM Could Turn Profitable (JNJ, IBM)

    March 12, 2016
    Learn why Johnson & Johnson teamed up with IBM, and which patient mobile apps will be part of their medical data analysis ...
  96. Is Big Pharma Under Pressure in 2016? (JNJ, GSK)

    March 8, 2016
    Find out why large pharmaceutical companies are coming under pressure by investors to break themselves up into smaller companies.
  97. Analyzing Johnson & Johnson's Return on Equity (JNJ, PFE)

    March 6, 2016
    Learn about Johnson & Johnson's recent return on equity, what has driven the recent trends, and how it compares to competitors ...
  98. Johnson & Johnson's Partnership with Nextera (JNJ)

    March 6, 2016
    Learn more about the research partnership between Johnson & Johnson subsidiary, Janssen Biotech, and Nextera, a Norwegian ...
  99. 3 Healthcare Stocks Near Their 52-Week Highs Worth Selling (MDT, ...

    March 2, 2016
    Identify three health care stocks that are trading near their 52-week highs that might be worth selling given the uncertainty ...
  100. Johnson & Johnson's 3 Key Financial Ratios (JNJ)

    February 29, 2016
    Learn about Johnson & Johnson and its financial ratios, such as operating margin, return on invested capital (ROIC) and capital ...
  • Showing 1-100 of 196 items
  • 1
  • 2
  • >>